The company behind an AI tool that digs through business documents just hired a new chief financial officer. After using the platform for years as an investor, she now runs its finances. The tool indexes over half a billion documents—SEC reports, earnings calls, research papers—so finance teams can
A new survey shows that nine out of ten people in the United States want to be able to move their phones when they change providers. The study was done by Fabrizio Ward and it found that 93 % of voters think unlocking a phone should be as simple as keeping their number. Support is strong acros
New Mexico’s doctors get judged by raw numbers—like how 0. 7% account for half the malpractice payouts in the state. But putting neurosurgeons in the same group as skin doctors misses a key fact: brains and spines are far riskier to operate on. Research shows neurosurgeons are sued far more often th
Most Australians over 55 rarely break a sweat. Official guidelines say we should move more—every week, in every way—but most of us still end up parked on the couch. A fresh approach called VILPA flips the script. Instead of gym sessions, VILPA nudges people to sprinkle short bursts of hard effort in
Danone, the big French food company, announced it will purchase Huel, a maker of ready‑to‑drink protein shakes. The deal reflects how young people are looking for quick, healthy meals and how new weight‑loss medicines are changing eating habits. Huel offers drinks packed with protein, fibre and o
The question is simple: are you happy? When people pause from daily worries and look inward, many say no. A recent survey of American readers revealed a mix of dissatisfaction and a few hopeful voices, but overall the mood skews toward unhappiness. The United States ranks 23rd in a global happine
Hyo Joo Kim finished the Fortinet Founders Cup at Sharon Heights with a 9‑under 63, thanks to an eagle on the final par‑5. The morning round set the stage; greens were still soft, making close shots tough. Kim kept her mistakes in check and avoided any bogeys throughout the day. Her final hole
Millions of people use GLP‑1 drugs like Ozempic or Wegovy to lose weight. They often ask: what will happen once the injections end? Older clinical trials said people would gain back much of the weight quickly. These studies were very controlled and did not show what happens in everyday life
A new study shows that the heart protection you get from GLP‑1 medicines fades quickly once you stop taking them. Researchers examined records of more than 333, 000 people with type‑2 diabetes who were treated through the Veterans Health Administration. Those on GLP‑1 drugs, such as semaglutide (Oze
The Seattle Mariners recently made some changes to their roster, sending a few players to the minors. Among them was Troy Taylor, a pitcher who had shown a lot of promise but has since faced some challenges. Taylor is known for his impressive skills. He has a fastball that can reach speeds of mid-9
